CHICAGO – November 1, 2018 – PRESS RELEASE – Cresco Labs, one of the largest multi-state, vertically integrated cannabis operators in the United States, is celebrating its pilot harvest from its seven-acre production site located in the central coast of California. In partnership with a well-established horticultural producer in the region, Cresco has implemented the highest standard in medical cannabis production to cultivate high-quality, third party-certified cannabis products for the California adult-use market. Including the central coastal California cultivation production site, Cresco Labs will operate two cultivation/processing, one extraction and one distribution facility in the state of California.
“This first harvest in California is an exciting milestone for our company and great news for the California adult-use market that favors premium, hand-selected strains of connoisseur-quality cannabis,” said Cresco Labs CEO and co-founder Charlie Bachtell. “We are offering the highest quality extract products certified according to the most stringent testing thresholds required in medical cannabis markets to ensure complete product safety. Our flagship offering from Central California introduces four top quality strains with dozens more currently being selected and under development.”
Cresco Labs’ testing process couples in-house protocols combined with certified laboratory testing. Flowers, concentrates and/or edible products are market ready only if the following four testing parameters meet or exceed established thresholds: total cannabinoid potency analysis, visual contaminant, pesticide residue and microbial contamination. In early 2019, Cresco plans to roll out its full suite of consistently dosed products in the California market including flower, edibles, vape pens/cartridges and multiple forms of extracts under the brand names of Cresco, Remedi, Reserve and Mindy's Edibles, an infused edible line with James Beard Award-Winning Chef Mindy Segal.
